World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
75
Citations
52206
World Ranking
18950
National Ranking
1712

Philip Home publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Philip Home sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 487 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Philip Home D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Philip Home sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 75 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Philip Home is affiliated with Newcastle University in the United Kingdom and has contributed extensively to the field of Medicine, with a particular focus on Endocrinology, Diabetes, and Metabolism.

The scientist's research spans several subfields including:

  • Endocrinology, Diabetes and Metabolism
  • Molecular Biology
  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pharmacology

Main topics covered in their work include:

  • Diabetes Treatment and Management
  • Diabetes Management and Research
  • Metabolism, Diabetes, and Cancer
  • Pancreatic function and diabetes
  • Cardiovascular Function and Risk Factors
  • Pharmacology and Obesity Treatment
  • COVID-19 Clinical Research Studies

Philip Home has published numerous papers, some of the recent notable ones are:

  • Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure (2020), published in New England Journal of Medicine
  • Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease (2020), published in New England Journal of Medicine
  • Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes (2021), published in Diabetes Care
  • Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial (2020), published in The Lancet Neurology
  • The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial (2020), published in The Lancet Diabetes & Endocrinology

The scientist often collaborates with frequent co-authors including:

  • Hertzel C. Gerstein
  • Lawrence A. Leiter
  • Jeffrey L. Probstfield
  • Rafael Díaz
  • Mark Lakshmanan

Philip Home's work appears regularly in several publication venues, with repeated contributions to:

  • Diabetes Care
  • UNC Libraries
  • Diabetes
  • Diabetes Obesity and Metabolism
  • Cardiovascular Diabetology

Best Publications

  • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

    R C Turner;R R Holman;C A Cull;I M Stratton

  • European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

    Guy De Backer;Ettore Ambrosioni;Knut Borch-Johnsen;Carlos Brotons

  • Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

    Philip D. Home;Stuart J. Pocock;Henning Beck-Nielsen;Paula S. Curtis

  • Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.

    Philip D. Home;Stuart J. Pocock;Henning Beck-Nielsen;Ramón Gomis

  • A desktop guide to Type 2 diabetes mellitus

    M. Aguilar;K. G.M.M. Alberti;S. A. Amiel;J. Azzopardi

  • A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 Diabetes

    Kjeld Hermansen;Melanie Davies;Taudeusz Derezinski;Gabrielle Martinez Ravn

  • A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

    J. Rosenstock;M. Davies;P. D. Home;J. Larsen

  • Principles for National and Regional Guidelines on Cardiovascular Disease Prevention A Scientific Statement From the World Heart and Stroke Forum

    Sidney C. Smith;Rod Jackson;Thomas A. Pearson;Valentin Fuster

  • The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease

    Latika Sibal;Sharad C Agarwal;Philip D Home;Rainer H Boger

  • New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using basal and mealtime insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 1)

    Matthew C. Riddle;Geremia B. Bolli;Monika Ziemen;Isabel Muehlen-Bartmer

  • New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)

    G B Bolli;M C Riddle;R M Bergenstal;M Ziemen

  • Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients.

    B. O. Boehm;P. D. Home;C. Behrend;N. M. Kamp

  • Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin A 24-week, randomized, placebo-controlled comparison (GetGoal-l)

    Matthew C. Riddle;Ronnie Aronson;Philip Home;Michel Marre

  • Guidelines for the treatment and management of new-onset diabetes after transplantation

    Alan Wilkinson;Jaime Davidson;Francesco Dotta;Philip D Home

  • Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial

    P. D. Home;A. Lindholm;A. Riis

  • Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.

    P D Home;A Lindholm;B Hylleberg;P Round

  • Insulin Detemir Offers Improved Glycemic Control Compared With NPH Insulin in People With Type 1 Diabetes: A randomized clinical trial.

    Philip Home;Paul Anthony Bartley;David Russell-Jones;Helene Hanaire-Broutin

  • Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial

    Michel Komajda;John J.V. McMurray;Henning Beck-Nielsen;Ramon Gomis

  • 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

    F Cosentino;P J Grant;V Aboyans;C J Bailey

  • Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert Forum.

    William T. Cefalu;George A. Bray;Philip D. Home;W. Timothy Garvey

Frequent Co-Authors

Geremia B. Bolli
Geremia B. Bolli University of Perugia
Nick Freemantle
Nick Freemantle University College London
Michel Marre
Michel Marre Université Paris Cité
Nicolas Danchin
Nicolas Danchin Université Paris Cité
Hannele Yki-Järvinen
Hannele Yki-Järvinen University of Helsinki
Henning Beck-Nielsen
Henning Beck-Nielsen Odense University Hospital
Stuart J. Pocock
Stuart J. Pocock London School of Hygiene & Tropical Medicine
Ryuzo Kawamori
Ryuzo Kawamori Juntendo University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn't always require a traditional path. Many students are now turning to online programs for greater flexibility and affordability. For those aiming to advance their nursing qualifications, the cheapest dnp programs can open doors to leadership and clinical specialist roles while allowing you to balance work and study.

If pharmacy is your passion, accredited pharmacy school online options make it possible to earn a doctorate without relocating or sacrificing current obligations.

For those interested in managing health data, pursuing a degree in health informatics is an excellent way to assemble skills at the intersection of healthcare and technology.

Alternatively, if you want to quickly enter the healthcare workforce, medical billing and coding online courses help you qualify for in-demand administrative careers.

These online options offer varied paths into healthcare, letting you fit your education around your life while preparing for rewarding roles.

Best Scientists Citing Philip Home

Trending Scientists

Recently Published Articles